Abstract
There is considerable interindividual variability in the effectiveness and safety of medicines. Although the reasons for this are multifactorial, it is well recognised that genetic changes impacting the absorption or metabolism of these drugs play a significant contributory role. Understanding how these pharmacogenetic variants impact response to medicines, and leveraging this knowledge to guide prescribing, could have significant benefits for patients and health services. This article provides an introduction to the field of pharmacogenetics, including its nomenclature, the existing evidence base and the current state of implementation globally. We discuss the challenges in translating pharmacogenetic research into clinical practice and highlight the considerable benefits which can emerge in those health services where implementation is successful.
Author supplied keywords
Cite
CITATION STYLE
McDermott, J. H., & Newman, W. (2023, November 1). Introduction to pharmacogenetics. Drug and Therapeutics Bulletin. BMJ Publishing Group. https://doi.org/10.1136/dtb.2023.000009
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.